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The syndrome of Relative Energy Deficiency in Sport (RED-S) includes wide-ranging effects on 26 
physiological and psychological functioning, performance, and general health. However, RED-S is 27 
understudied among male athletes at the highest performance levels. This cross-sectional study aimed 28 
to investigate surrogate RED-S markers prevalence in Norwegian male Olympic-level athletes. Athletes 29 
(N=44) aged 24.7±3.8 years, body mass 81.3±15.9kg, body fat 13.7±5.8%, and training volume 30 
76.1±22.9 hours/month, were included. Assessed parameters included resting metabolic rate (RMR), 31 
body composition, and bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA) and 32 
venous blood variables (testosterone, free triiodothyronine (fT3), cortisol and lipids). Seven athletes 33 
(16%) grouped by the presence of low RMR (RMRratio <0.90) (0.81±0.07 vs. 1.04±0.09, p<0.001, effect 34 
size 2.6), also showed lower testosterone (12.9±5.3 vs. 19.0±5.3 nmol·l-1, p=0.020) than in normal RMR 35 
group. In low RMRratio individuals, prevalence of other RED-S markers (—subclinical— low 36 
testosterone, low fT3, high cortisol and elevated LDL) was (N/number of markers): 2/0, 2/1, 2/2, 1/3. 37 
Low BMD (z-score<-1) was found in 16% of the athletes, all with normal RMR. Subclinical low 38 
testosterone and fT3 levels were found in nine (25%) and two (5%) athletes, respectively. Subclinical 39 
high cortisol was found in 23% of athletes while 34% had elevated LDL cholesterol levels. Seven of 40 
twelve athletes with 2 or more RED-S markers had normal RMR. In conclusion, this study found that 41 
multiple RED-S markers also exist in male Olympic-level athletes. This highlights the importance of 42 
regular screening of male elite athletes, to ensure early detection and treatment of RED-S. 43 
 44 
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Relative Energy Deficiency in Sport (RED-S) describes a syndrome with impairment of numerous 48 
physiological systems, triggered by low energy availability (LEA) (Mountjoy et al., 2018; Mountjoy et 49 
al., 2014). LEA with or without disordered eating (DE) behaviors, impose serious health-risks 50 
potentially with clinical manifestations such as endocrine alterations, reproductive function, impaired 51 
bone health and cardiovascular risk factors (De Souza et al., 2014; Elliott-Sale et al., 2018; Gibbs et al., 52 
2013; Logue et al., 2020a; McCall & Ackerman, 2019; Melin et al., 2019; Mountjoy et al., 2018; 53 
Mountjoy et al., 2014; Nattiv et al., 2007). Until recently, research related to LEA has been 54 
predominantly performed in female athletes (De Souza et al., 2014; Logue et al., 2020a; Mountjoy et 55 
al., 2018; Mountjoy et al., 2014; Nattiv et al., 2007), competing in sport disciplines where leanness 56 
and/or a low body weight is directly (power-to-weight ratio) or indirectly (appearance) related to 57 
performance or  a specific body weight as a requirement to compete (weight category sports) (Gibbs et 58 
al., 2013; Martinsen et al., 2010; Mountjoy et al., 2018; Sundgot-Borgen, 1993; Sundgot-Borgen et al., 59 
2013; Sundgot-Borgen & Torstveit, 2010).  60 
In males, similar negative metabolic and endocrine alterations have been observed, as well as reductions 61 
in testosterone levels, which may be associated with reproductive dysfunction, impaired performance, 62 
injuries and poor bone health, (De Souza et al., 2019; Elliott-Sale et al., 2018; Friedl et al., 2000; Heikura 63 
et al., 2018b; Klomsten Andersen et al., 2018). Elite athletes often have high training loads and  energy 64 
expenditure, demanding an increase in energy intake which, if not addressed by an accompanying 65 
increase in energy intake, may amplify the risk of LEA (Burke et al., 2018). Furthermore, elite athletes 66 
in leanness sports may be particularly vulnerable to LEA due to the desire to remain light and lean, with 67 
many acknowledging the use of increased training load to facilitate body composition adaptations 68 
(Gibbs et al., 2013; Martinsen et al., 2010; Sundgot-Borgen, 1993; Sundgot-Borgen et al., 2013; 69 
Sundgot-Borgen & Torstveit, 2010). The incidence of LEA in world-class male elite endurance athletes 70 
has been reported to be 25% (Heikura et al., 2018b). Due to potential adverse implications, the 71 
development of tools to identify male athletes at risk for RED-S is therefore warranted (Mountjoy et al., 72 
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2018). Preliminary research suggests that males may withstand a lower threshold of LEA compared to 73 
females (Koehler et al., 2016; Papageorgiou et al., 2017), however, EA is difficult to assess, making it 74 
challenging to use as a practical and reliable measure (Areta et al., 2021; Burke et al., 2018; De Souza 75 
et al., 2019; Heikura et al., 2018b). Furthermore, no validated screening tools like the "Low Energy 76 
Availability in Females Questionnaire" currently exists for use with males. In total, RED-S in male 77 
athletes is understudied with only a few studies investigating RED-S amongst elite male endurance 78 
athletes (Heikura et al., 2018a; Heikura et al., 2018b; Logue et al., 2020b), including non-leanness 79 
athletes (Logue et al., 2020a; Logue et al., 2020b; Tenforde et al., 2016).  80 
The aim of this study was to investigate RED-S in a Norwegian cohort of male Olympic-level athletes 81 
using surrogate markers such as suppressed resting metabolic rate (RMR), impaired bone health, and 82 
altered metabolic and endocrine variables.  83 
 84 
Material and methods 85 
Study design and recruitment 86 
This study was designed as a cross-sectional study. Athletes were recruited through the Norwegian 87 
Olympic and Paralympic Committee and Confederation of Sports. The study was approved by the 88 
Norwegian Regional Committees for Medical and Health Research Ethics (2017/2160) and the 89 
Norwegian Centre for Research Data (56937/3/STM/LR) and conducted following the 2013 Declaration 90 
of Helsinki. Inclusion criteria were senior athlete ≥18 years of age, competing at a national team level 91 
in road-cycling, long- and middle-distance running, triathlon, race-walking, rowing, wrestling, biathlon, 92 
Nordic combined, cross-country skiing, boxing, powerlifting, soccer, or handball. The exclusion criteria 93 
were injuries preventing athletes from participating in their regular training regimen. The recruitment 94 
process involved announcements and distributions of invitations via email to both national coaches and 95 
athletes, intending to encourage participation. Interested athletes received written information about the 96 
study, and those interested in participation signed an informed consent. In total, 44 Olympic-level male 97 
athletes accepted participation, competing in the following sports: road-cycling, triathlon, race-walking, 98 
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light-weight rowing, wrestling, biathlon, Nordic combined, cross-country skiing, kickboxing, 99 
powerlifting competing in high weight-classes (≥93kg), and handball.   100 
Assessment protocol 101 
All tests were performed from January to March 2018, between 5-9 a.m. starting with RMR 102 
measurements, followed by body composition and BMD assessment before blood sampling.  103 
Resting metabolic rate 104 
Athletes either slept overnight at the laboratory in Oslo, Norway or arrived in a 12-hour fasted and rested 105 
state using motorized transport with minimal bodily movement. On arrival, subjects were placed in a 106 
quiet and dimly lit room maintained at a constant temperature (21°C). For a detailed description of 107 
measurement, see Table 1.   108 
Body composition and bone health 109 
Following RMR assessment, stretch stature, body weight, body composition and BMD were measured 110 
as described in Table 1.  111 
Biochemical markers 112 
A venous blood sample was drawn as described in Table 1, and serum was analysed at commercial 113 
clinical laboratory (Fürst, Oslo, Norway).  114 
Insert Table 1 here 115 
RED-S criteria 116 
Following the procedure of Heikura et al. (2018b), athletes were given a score based on a positive- (1 117 
point) or a negative (0 points) prevalence related to the following symptoms of RED-S; low body fat  118 
defined as <5% (Sundgot-Borgen et al., 2013), underweight defined as BMI <18.5 kg·m2 (Sundgot-119 
Borgen et al., 2013), low BMD, defined as a Z-score <-1 in lumbar spine or femur neck (Nattiv et al., 120 
2007), low RMR, defined as an RMRratio<0.90 using the Cunningham (1980) equation (Strock et al., 121 
2020b), subclinical low testosterone, defined as within the lowest quartile of clinical range defined by 122 
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the laboratory (<14.8 nmol·l-1) or fT3 (<4.3 pmol·l-1), subclinical high cortisol (defined as within the 123 
highest quartile of clinical range) (>537 nmol·l-1) or elevated LDL levels (>3.0 mmol·l-1).  124 
Statistics 125 
Data were analyzed using STATA for Windows (v. 16; Stata Corp LCC, College Station, TX, USA). 126 
The dataset was controlled for signs of non-normality using histograms, QQ-plot, and the Shapiro-Wilk 127 
test. Athletes (n=44) were included and divided into two groups based on energetic status (low vs normal 128 
RMR) (Strock et al., 2020b). Differences between energetic status were assessed using the welch test 129 
for unequal variances. Contingency data were analyzed using the Fisher exact test. Between group 130 
differences are expressed with Cohen's D effect size (ES) with the following threshold; trivial (<0.2), 131 
small (0.2-0.5), moderate (0.5-0.8), and large (>0.8). Relationships between RED-S variables were 132 
investigated using linear regression. Statistical significance level was defined as p<0.05, and data are 133 
presented as mean ± standard deviation.  134 
Results 135 
Descriptive data are presented in Table 2.  136 
Insert Table 2 here 137 
RED-S criteria 138 
Of the 44 athletes, 32 (73%) had either 0 or 1 RED-S criteria present seven athletes (16%) presented 139 
with 2 criteria, four athletes (9%) with 3 criteria, and one athlete (2%) with 4 criteria (Figure 1).  Detailed 140 
criteria points, including absolute values for all athletes with low RMR are presented in Table 3, 141 
including all athletes with low BMD independent of the presence of other markers, as well as two 142 
athletes with 3 simultaneously present criteria other than low RMR. 143 
Insert Figure 1 and Table 3 here 144 
RED-S surrogate markers 145 
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Table 4 summarizes the RED-S surrogate markers investigated according to energetic status, while 146 
Figure 2 summarizes RED-S markers. Overall, the low RMR group had lower testosterone compared to 147 
the normal RMR group (Table 4). No significant linear relationship was found between RMRratio and 148 
surrogate biochemical markers of RED-S (p>0.05). 149 
Insert Table 4 here 150 
None of the athletes had low body fat or were underweight. Of the 44 athletes included, seven (16%) 151 
had low RMRratio. Of these seven athletes, two athletes had no other RED-S marker present, two athletes 152 
had one marker present, two athletes had two markers present, while one athlete had three other RED-153 
S markers present simultaneously. Seven athletes (16%) had low BMD in the lumbar spine, with four 154 
of them having no other RED-S marker present. A total of eleven athletes (25%) had subclinical low 155 
testosterone levels, including one athlete with clinically low levels (<8 nmol·l-1). Two athletes (5%) had 156 
subclinical low fT3. Ten athletes (23%) had subclinical high cortisol, and 15 athletes (34%) had elevated 157 
LDL levels.  158 
Leanness vs. non-leanness athletes 159 
Thirty-four of the athletes participated in leanness sports, while the remaining 10 were involved in non-160 
leanness sports. No significant differences in prevalence were observed between leanness and non-161 
leanness athletes (Figure 2). 162 
Insert Figure 2 here 163 
Discussion 164 
This is one of few studies investigating surrogate markers of RED-S in a larger group of Olympic-level 165 
male athletes, including both leanness- and non-leanness sports athletes (Drew et al., 2018; Drew et al., 166 
2017). The primary findings of this investigation were that most athletes displayed none or few single 167 
markers related to RED-S independent of current low RMR. However, seven athletes (16%) were 168 
identified with low RMR with the majority of these displaying additional RED-S markers. LEA can be 169 
present with or without DE  behaviors and is more prevalent among female athletes, especially in sports 170 
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where leanness is associated with performance (Gibbs et al., 2013; Mountjoy et al., 2014; Sundgot-171 
Borgen, 1993; Sundgot-Borgen et al., 2013; Sundgot-Borgen & Torstveit, 2010; Tenforde et al., 2016). 172 
Hence, screening and identifying athletes at risk of DE behaviors is therefore important, however, is 173 
time consuming and requires the expertise of a multi-disciplinary team (Wells et al., 2020). 174 
Prevalence of clustered RED-S markers 175 
The prevalence of RED-S in athletes has been reported to range between 22-58% (Logue et al., 2020a). 176 
However, few of these studies have investigated male athletes at elite- or Olympic levels. In a study by 177 
Heikura et al. (2018b), 25% of their world-class male middle- and long-distance runners and racewalkers 178 
were identified with LEA, with significant lower testosterone levels in the LEA-group. Assessing RED-179 
S related markers, 40% of their population also had lower testosterone and T3 levels, including a  4.5 180 
times greater incidence of bone injury in these athletes, despite BMD being unimpaired, but did not 181 
assess RMR (Heikura et al., 2018b). Woods et al. (2017) reported reduction of ~2 kcal·kgFFM-1·day-1 182 
in RMR and body weight in elite rowers undertaking a 4-week intensified training period, without an 183 
apparent increase in EI. We recently reported a case study on a male combat athlete cutting weight for 184 
competition during 7 weeks of EA ~20 kcal·kgFFM-1·day-1 and 1 week ~3 kcal·kgFFM-1·day-1, showing 185 
a clear concomitant decrease of RMRratio under 0.9 (Cunningham, 1980) and RED-S markers falling 186 
outside clinical reference ranges (Langan-Evans et al., 2020). Similarly, in the current study, we 187 
identified seven athletes (16%) with low RMR, five of whom had multiple other RED-S markers, such 188 
as subclinical low testosterone and fT3, subclinical high cortisol and elevated LDL. Interestingly, we 189 
also identified two athletes without low RMR, yet with 3 other RED-S markers present, such as 190 
subclinical low testosterone, low BMD, subclinical high cortisol, and elevated LDL, warranting further 191 
scrutiny (Table 4). However, our findings provide preliminary data suggesting that RMRratio may be a 192 
practical tool to identify athletes at risk of RED-S, representing a novel approach attempting to overcome 193 
the difficulties of assessing EA (Areta et al., 2021; Burke et al., 2018; De Souza et al., 2019).  194 
Metabolic alterations 195 
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FFM is one of the most significant determinants of RMR, and reductions in RMR have been reported in 196 
male athletes with LEA(Torstveit et al., 2018; Woods et al., 2017; Woods et al., 2018). When energy 197 
availability is insufficient for basal physiological processes, the body prioritizes processes essential for 198 
survival, reducing RMR to conserve energy, including suppression of reproduction, growth, 199 
metabolism, and bone formation (De Souza et al., 2019; Mountjoy et al., 2014; Nattiv et al., 2007). An 200 
RMRratio of <0.90 has been recognized as a surrogate marker of LEA in exercising females (McCall & 201 
Ackerman, 2019; Strock et al., 2020a; Strock et al., 2020b). Furthermore, research by Strock and 202 
coworkers has identified that RMRratio accurately reflects total T3 status in females, making it a useful 203 
marker of prolonged energy deficiency (Strock et al., 2020a; Strock et al., 2020b). In our study, seven 204 
athletes had low RMR, with five of them also having subclinically low testosterone. Interestingly, five 205 
out of seven of these athletes had very low RMR, ranging from 0.68-0.83 (Table 3), with similar deficits 206 
to that observed in females with anorexia nervosa (Marra et al., 2002). Most athletes with low RMR also 207 
presented subclinically low testosterone levels, strengthening a link to LEA, similar to the findings of 208 
Heikura et al. (2018b). However, rather than using RMRratio as a sole diagnostic tool, a combination with 209 
other markers such as hypotension, underweight and subclinically low testosterone levels in males are 210 
recommended (Staal et al., 2018). Furthermore, the 0.90 cut-off point was initially established in 211 
exercising females (De Souza et al., 2008), making it to some extent challenging to apply to athletes, 212 
who generally have a higher fat-free mass compared to non-athletes. Finally, though we acknowledge 213 
that selecting the Cunningham (1980) equation among different predictive formulas for the RMRratio cut-214 
off of 0.90 may appear arbitrary, a strong rationale for the use of this predictive equation exists: 1) The 215 
few studies in males in this area also utilized the Cunningham (1980) equation, making our results 216 
comparable to others in the current literature (Langan-Evans et al., 2020; Torstveit et al., 2018; Torstveit 217 
et al., 2019; Wilson et al., 2018),  and 2) we observed a very large effect size (Cohen’s d 2.6 (95% CI 218 
1.6-3.6), Table 4) in the low RMRratio group compared to the normal RMR which would yield similar 219 
results using other formulas giving slightly different RMRratio values. We are aware of the importance 220 
of comparison of different equations and the need for further exploration of cut-off values in males to 221 
define presence of adaptive thermogenesis. However, such exploration is beyond the scope of the current 222 
work and we hope that the findings of this study provide evidence to substantiate further research to 223 
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establish whether the proposed cut-offs are transferrable to males (Strock et al., 2020a; Strock et al., 224 
2020b) as well as how RED-S markers are related to low RMR in males.  225 
T3 is essential for growth, metabolism, and reproduction with ties to LEA (Elliott-Sale et al., 2018). As 226 
a result of reduced energy intake, the hypothalamic-pituitary-thyroid axis adapts and alters levels of both 227 
T3 and thyroxine to conserve energy for vital functions (Logue et al., 2020a; McCall & Ackerman, 228 
2019). T3 might also be a more useful marker of LEA than other thyroid function tests in males (McCall 229 
& Ackerman, 2019). Furthermore, low T3 levels have frequently been linked to low testosterone levels 230 
(De Souza et al., 2019; Friedl et al., 2000; Heikura et al., 2018b; McCall & Ackerman, 2019). In our 231 
study, two athletes displayed subclinical low fT3. Only one of these athletes belonged to the energy 232 
deficit group, and also displayed very low RMRratio (0.77) and clinical low testosterone levels (4.3 233 
nmol.l-1). In a study on male special forces soldiers experiencing prolonged starvation, researchers 234 
observed substantial reductions of both T3 and testosterone during the eight-week course (Friedl et al., 235 
2000). In the Heikura et al. (2018b) study, athletes with low testosterone had lower T3 levels compared 236 
to athletes with normal testosterone levels, while no difference were observed between the groups of 237 
LEA and moderate EA. Similar T3 findings are observed in studies were recreational trained males are 238 
exposed to short periods of LEA (⁓15 kcal·kg-1FFM·day-1) compared to optimal EA (40-45 kcal·kg-239 
1FFM·day-1), possibly due to males being less sensitive to short periods of LEA compared to females 240 
(Koehler et al., 2016; Papageorgiou et al., 2017). In our study, athletes with severe low RMR did not 241 
show signs of subclinical low fT3, warranting more research to explore the relation between LEA, RMR 242 
and fT3 in males.  243 
Reproductive function 244 
Indisputable evidence shows that shorter periods of LEA causes suppression of reproductive- and 245 
metabolic functions in females (Loucks & Thuma, 2003), however, this is not fully understood in male 246 
athletes, and evaluation is difficult and may require sperm analysis (De Souza et al., 2019; Elliott-Sale 247 
et al., 2018; Tenforde et al., 2016). It has been stated that testosterone in males plays a critical role in 248 
both sexual, bodily development, and cognitive aspects as well as physiological advantage in sports 249 
performance (Hackney, 2020). Research on male soldiers undergoing prolonged starvation has shown 250 
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dramatic reductions in testosterone levels (Friedl et al., 2000). In male long-distance runners, race 251 
walkers and cyclists, LEA has been reported to strongly correlate with reduced testosterone levels 252 
(Heikura et al., 2018b; Keay et al., 2018; Melin et al., 2019). Experimental data has shown a causal 253 
effect between LEA and reduced testosterone only in one (Kojima et al., 2020) out of two studies 254 
(Koehler et al., 2016). In our study, a total of 11 athletes (25%) had sub-clinically low testosterone. 255 
However, our subclinical low testosterone levels findings may arise from hypogonadotropic 256 
hypogonadism (Arce et al., 1993; De Souza et al., 1994; De Souza et al., 2019; Tenforde et al., 2016) or 257 
the Exercise Hypogonadal Male Condition (EHMC), a maladaptation within the reproductive system 258 
due to athletes persistent and chronic exposure to large volumes of exercise training (Hackney, 2020). 259 
The first findings of lower total and free testosterone levels in male athletes compared with sedentary 260 
controls were reported by Arce et al. (1993) and De Souza et al. (1994). The subclinical testosterone 261 
levels were associated with low normal sperm count, decreased motility and morphological changes that 262 
may compromise fertility (Arce et al., 1993). These findings were confirmed in a large, randomised 263 
training study (n=286) where subjects were assigned to five 120-minute sessions/week of moderate-264 
intensity exercise (60% of VO2max) or high-intensity exercise (80% VO2max) (Safarinejad et al., 2009). 265 
The results demonstrated that strenuous long-term exercise with significant weight loss resulted in a 266 
significant decrease in plasma sex hormone concentrations and impaired reproductive capacity. Re-267 
analyzing previous data, Hackney and Lane (2018) found a ~30-35% reduction in testosterone levels in 268 
endurance-trained distance runners with ≥5 years- compared to those with <5 years of endurance training 269 
experience, although the reduction was unlikely to be caused by LEA, since no other health problems 270 
were reported (Hackney, 2020). In the Heikura et al. (2018b) study, low testosterone was found in 40% 271 
of participants. However, no differences in EA between the groups were reported, although athletes with 272 
LEA had significant lower testosterone levels compared to the moderate EA group. In the Koehler et al. 273 
(2016) study, no reductions in testosterone levels between groups were found. It is unclear whether the 274 
four-day period of LEA was long enough to observe changes in subclinical markers in the latter study 275 
(Koehler et al., 2016). Establishing baseline values for endocrine markers may be warranted, where 276 
sudden and unexpected drops in values should trigger further investigations into the cause to distinguish 277 
between the potential onset of RED-S or EHMC. However, broad scientific evidence supports the fact 278 
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that LEA causes reduction in testosterone, and that low testosterone levels are detrimental for 279 
performance (Hackney, 2020; Hackney et al., 2017). Thus, it is interesting to observe that subclinically 280 
low testosterone is present among almost all athletes with low RMR (Table 4), strengthening the 281 
association to LEA among these athletes (Arce et al., 1993; De Souza et al., 1994; De Souza et al., 2019; 282 
Hackney, 2020; Tenforde et al., 2016).  283 
Impaired bone health 284 
Several parameters influence bone health, mostly endocrine and nutritional aspects, as well as 285 
mechanical loading. Long term LEA is strongly linked to impaired bone health in female athletes (De 286 
Souza et al., 2014; Mountjoy et al., 2018; Mountjoy et al., 2014; Nattiv et al., 2007) and data on male 287 
athletes are now emerging (Barrack et al., 2017; Heikura et al., 2018b; Klomsten Andersen et al., 2018; 288 
Kraus et al., 2019; Papageorgiou et al., 2017; Tenforde et al., 2018; Viner et al., 2015). This includes 289 
increased risk of bone stress injuries among runners (Barrack et al., 2017; Kraus et al., 2019; Tenforde 290 
et al., 2018), as well as high prevalence of low BMD among cyclists (Klomsten Andersen et al., 2018; 291 
Viner et al., 2015). Viner et al. (2015) found a high prevalence of both LEA (70%) and low BMD (40%) 292 
across a professional cycling season, and Klomsten Andersen et al. (2018) found that 58% of elite 293 
cyclists had low BMD. In a randomized controlled trial, Papageorgiou et al. (2017) found decreased 294 
bone formation and increased bone resorption in females exposed to LEA, but not in males. Researchers 295 
speculate whether the 5-day LEA restriction among males was insufficient to see such changes, 296 
emphasizing the need for more research in this field (Papageorgiou et al., 2017). In a study by Heikura 297 
et al. (2018a), they reported no associations between the incidence of LEA and low BMD among world-298 
class male endurance athletes. In our study, seven athletes (16%) were identified with low BMD, with 299 
or without other RED-S markers, highlighting the importance of screening athletes for low BMD 300 
independent of the presence of other signs of RED-S. BMD is, affected by an array of variables such as 301 
a chronic energy deficiency in the past, family history of osteoporosis, physical activity level, sedentary 302 
lifestyle, and dietary intake (Nattiv et al., 2007), variables which we did not assess. Finally, screening, 303 
and early detection of declining BMD are especially important in athletes at risk of LEA due to the 304 




Cortisol, a steroid hormone related to stress, is likely to contribute to increased adiposity during energy 307 
abundance and is an essential catabolic hormone secreted to ensure glucose homeostasis during 308 
prolonged exercise and starvation (Elliott-Sale et al., 2018). Increases in cortisol during severe caloric 309 
restriction and fasting has been observed in humans, and hypercortisolemia might directly affect 310 
reproductive function or serve as a biomarker of stress and reproductive dysfunction in amenorrheic 311 
athletes (Elliott-Sale et al., 2018). The role of cortisol in relation to LEA in male athletes is not fully 312 
understood. Studying American soldiers, Friedl et al. (2000) suggested that augmented cortisol levels 313 
were associated with reduced body fat after four weeks of semistarvation during military training. In 314 
support of this, the soldier with the highest observed levels of cortisol began the course with minimal 315 
fat-reserves and lost most bodyweight (Friedl et al., 2000). In a recent study by Torstveit et al. (2018), 316 
a larger single-hour energy deficit was associated with higher cortisol values among well-trained male 317 
endurance athletes. Another study found that higher exercise dependency scores were associated with a 318 
more negative energy balance and higher cortisol levels among well-trained male cyclists and runners 319 
(Torstveit et al., 2019). In contrast, cortisol did not differ between a group of nine male long-distance 320 
runners with LEA compared to eight non-athletes with optimal EA (Hooper et al., 2017). We observed 321 
a 23% prevalence of athletes with subclinically high cortisol levels in our study. Furthermore, high 322 
cortisol levels (one clinical and two subclinical) were present among three athletes in combination with 323 
other RED-S markers (Table 3). However, cortisol as a marker itself of LEA should be interpreted with 324 
care, especially since stress and exercise per se is known to acutely increase cortisol levels (Hackney, 325 
2020) with elite athletes exhibit large training volumes (Woods et al., 2017). More in-depth research is 326 
needed to better understand the effects of LEA on cortisol especially in the male population (Elliott-Sale 327 
et al., 2018).  328 
Cardiovascular health  329 
Cardiovascular risk factors in both male and female athletes related to LEA is understudied. In females, 330 
unfavorable lipid profiles in amenorrhoeic athletes, with elevated TC and LDL levels, have been 331 
reported (Melin et al., 2019; Rickenlund et al., 2005). The mechanism for an impaired lipid profile in 332 
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amenorrhoeic athletes is suggested to be related to estrogen deficiency, since increased levels of LDL 333 
have been associated with hypogonadotropic hypogonadism in anorexia nervosa patients (Meczekalski 334 
et al., 2013), and athletes with amenorrhea (Rickenlund et al., 2005). However, elevated TC and LDL 335 
levels has also been reported in female eumenorrheic athletes with current low or reduced EA and/or 336 
disordered eating behavior, suggesting that alterations in cholesterol synthesis might be triggered by 337 
energy deficiency, despite normal weight and normal estrogen levels (Melin et al., 2015). Therefore, 338 
more research is needed to establish whether cardiovascular outcomes in female athletes can occur 339 
independent of estrogen deficiency. Research on male athletes is even more limited. Friedl et al. (2000), 340 
observed a progressive increase in both total-, LDL- and high-density lipoprotein (HDL) during the 8-341 
week military course, potentially related to changes in thyroid hormones and insulin-like growth factor 342 
1 (IGF-1). Male judo players (n=11) undergoing a self-selected 7-day energy restriction prior to 343 
competition showed no changes in TC, LDL, or HDL (Filaire et al., 2001). In our study, one-third of the 344 
total sample displayed elevated LDL levels. We were, however, not able to investigate the athletes' 345 
family history or diet to explore for potential dietary causes of elevated blood lipids. More research on 346 
risk factors for cardiovascular health among male athletes is needed to improve the understanding of the 347 
complexity and possible link to RED-S.  348 
Leanness vs. non-leanness athletes 349 
Most of the investigated RED-S signs were also present among the investigated non-leanness athletes. 350 
These signs included low RMR, low BMD, subclinical low testosterones, subclinical high cortisol, and 351 
elevated LDL (Figure 2). A priory, we expected that athletes belonging to leanness sports would be 352 
more prone to exhibit a higher prevalence of surrogate markers of RED-S. Therefore, we hypothesized 353 
that male leanness athletes would exhibit both higher incidence and more severe cases of RED-S. 354 
Unfortunately, the small sample size in this study makes the sample highly biased and should be taken 355 
into consideration when interpreting the results. Despite this, it is still interesting to observe that some 356 
non-leanness athletes displayed signs of energetic deficit in combination with other RED-S markers, 357 
warranting further investigations among this group of athletes.    358 
15 
 
 In conclusion, symptoms of chronic energy conservation related to RED-S were found in this group of 359 
Norwegian male Olympic-level athletes. Seven athletes (16%) had low RMR among this group of 360 
athletes, with the majority clustering with several additional RED-S markers, emphasizing the needs to 361 
further scrutinize these athletes. Furthermore, several RED-S markers were identified independent of 362 
current low RMR, including low BMD, subclinical testosterone, subclinical low fT3 and subclinical high 363 
cortisol, emphasizing the need to further investigate the use of clustering of such RED-S risk factors 364 
among other groups of athletes.  365 
Strengths and limitations 366 
Although LEA underpins RED-S, it is well recognized that EA is notoriously difficult to assess and 367 
evaluate on free living athletes (Areta et al., 2021; Burke et al., 2018; De Souza et al., 2019; Heikura et 368 
al., 2018b). As an alternative approach to identify athletes at risk of RED-S, we chose to accurately 369 
quantify variables,  known to reflect adaptations to chronic energetic stress, such as RMR using a canopy 370 
hood, BMD and body composition using DXA, as well as blood sampling, as described in recent studies 371 
(Elliott-Sale et al., 2018; Heikura et al., 2018b; Koehler et al., 2016; Lee et al., 2020; Logue et al., 2020a; 372 
Staal et al., 2018; Woods et al., 2017; Woods et al., 2018). The limitations of this study are: 1) a cross-373 
sectional design does not enable establishing any cause-effect relationships, 2) lack of data on EA and 374 
no assessment of whether athletes prior to testing had attempted to moderate body mass, thus actively 375 
facilitating a state of LEA, 3) being weight stable at the time of testing were not part of the inclusion 376 
criteria, 4) the prevalence of athletes with clustering of RED-S markers may be influenced by athletes 377 
current training phase at time of testing (Heikura et al., 2018b; Woods et al., 2017), which was not 378 
controlled for, 5) the two groups representing low- and normal RMR, as well as leanness and non-379 
leanness differ in size, hence comparison should be interpreted with care, 6) not all athletes were tested 380 
during pre-season, due to practical reasons and 7) excluding injured athletes from participation may 381 
have induced a survivorship bias, and future research may include injured athletes in their analysis to 382 
get a better understanding of the RED-S syndrome. Finally, the use of upper and lower quartiles for 383 
normative ranges, compared to using clinical cut-offs, when interpreting hormones must be taken into 384 
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Table 1. Overview of methods used to assess and evaluate RED-S surrogate markers 
Component Summary of method Comments/references 
Resting metabolic rate (RMR)   
mRMR Indirect calorimetry using an automated system with a 
ventilated canopy hood (Vyntus CPX, CareFusion, 
Hoechberg, Germany, SentrySuite v. 2.21.4). The 
system was calibrated before each test following 
manufacturer directions. Participants laid in supine 
position for 5 minutes, before canopy was positioned. 
All were instructed to remain still and not fall asleep. 
VO2 and VCO2 were assessed over a 25-min period, 
and the last 20 min of measurements used to assess 
RMR. Typical error of measurement (CV%) for this 
methodology in the laboratory was 4.5% (95% 
confidence limits 3.5-6.2%)  
Compher et al. (2006) 
Areta et al. (2019)  
Weir (1990) 
pRMR 500 + 22 × LBM (kg) Cunningham (1980) based on 
Thompson and Manore (1996) 
RMRratio Calculated as mRMR/pRMR De Souza et al. (2008) 
Physique   
Body composition + 
BMD (femur neck and lumbar spine 
L1-L4) 
Via Dual-energy X-ray absorptiometry (DXA), strictly 
adhering to protocol. Urinary specific gravity was 
measured using a digital refractometer (Atago UG-α 
cat.no. 3464, Atago U.S.A Inc., Bellevue, WA). Scans 
were performed in the total body mode on a narrow 
fan-beam DXA scanner (Lunar iDXA, EnCore v. 
16.20 software, GE Healthcare, Madison, WI with the 
combined NHANES/Lunar reference database). The 
coefficient of variation for the laboratory was 0.0%, 
1.0%, 0.3%, 0.3% for body mass, fat mass, lean mass, 
and bone mass, respectively. All scans were conducted 
by the same technician using the standard thickness 
mode as determined by the auto-scan feature in the 
software and analysed automatically by the DXA 
software. 
Kerr et al. (2016) 
Nattiv et al. (2007) 
Mountjoy et al. (2014) 
Height Measured without shoes to the nearest 0.1 cm using a 
wall-mounted centimeter scale (Seca Optima, Seca, 
Birmingham, UK) 
 
Body weight Measured in underwear to the nearest 0.01 kg with an 
electronic scale (Seca, model 861, Birmingham, UK) 
 
BMI Total body weight (kg) / body height squared in meter 
(kg×m2) 
 
FFMI FFM (kg) / body weight squared in meter (kg×m2)  
FMI Fat mass (kg) / body weight squared in meter (kg×m2)  
Biochemical markers   
Blood sampling A venous blood sample was drawn from an antecubital 
forearm vein by a qualified nurse. 5 mL Vacuette Z 
Serum Sep clot activators were filled and subsequently 
centrifuged at 3000RPM for 10 minutes (Statspin 
Express 4, Beckman Coulter, CA, USA) within a limit 
of ≥ 20 minutes but ≤ 40 minutes. 2mL Cryotube vials 
were filled with serum and cooled to 2 degrees Celsius 
before being transported for analysis 
Blood was centrifuged at 
1500×g for 12 minutes and 
serum was analysed for total- 
and free testosterone (analytic 
CV 7.6%), free T3 (fT3; 3.0%), 
cortisol (8.2%), low-density 
lipoprotein (LDL; 2.0%) and 
total cholesterol (TC; 1.9%) 
BMD: bone mineral density, BMI: body mass index, FFM: fat-free mass, FFMI: fat-free mass index, FMI: fat mass index, LBM; 
lean body mass, mRMR: measured RMR, pRMR: predicted RMR, T3: Triiodothyronine   




Table 2. Descriptive characteristics of athletes in total and categorized according to energetic status 
Measurement Total 
n = 44 
Low RMR 
n = 7 
Normal RMR 
n = 37 
P-value Effect size 
(95% CI) 
Age (years) 24.8 ± 3.8 26.0 ± 3.3 24.6 ± 3.9  0.338 0.2 (-1.1-0.4) 
Stature (cm) 181.3 ± 8.4 177.9 ± 8.8 181.8 ± 8.2 0.297 0.5 (-0.3-1.3) 
Weight (kg) 81.3 ± 15.9 80.5 ± 19.1 81.5 ± 15.5 0.907 0.1 (-0.8-0.9) 
BMI (kg·m2) 24.7 ± 4.4 25.3 ± 4.4 24.6 ± 4.4 0.724 0.1 (-0.9-0.7) 
FFM† (kg) 69.4 ± 11.2 71.2 ± 12.9 69.0 ± 10.9 0.682 0.2 (-1.0-0.6) 
FFMI (kg·m2) 21.6 ± 2.7 22.4 ± 2.9 21.4 ± 2.7 0.425 0.2 (-1.2-0.4) 
FMI (kg·m2) 3.6 ± 2.4 3.2 ± 1.8 3.7 ± 2.5 0.567 0.2 (-0.6-1.0) 
Body fat† (%) 14.7 ± 6.9 12.2 ± 4.5 15.2 ± 7.2 0.167 0.4 (-0.6-1.0) 
Training volume (hours/month) 76.1 ± 22.9 72.9 ± 18.6 76.7 ± 22.7 0.638 0.2 (-0.6-1.0) 
L1-L4 Z-score† 0.59 ± 1.62 1.86 ± 1.92 0.35 ± 1.46 0.083 1.0 (0.2-1.8) 
Femur Z-score† 0.96 ± 1.14 1.33 ± 0.82 0.89 ± 1.19 0.280 0.3 (-0.3-0.5) 
Data are presented as mean ± standard deviation. P-value and ES indicates difference between low and normal RMR group. Effect 
size expressed as Cohens D with 95% confidence interval (CI), † measured by DXA. Abbreviations:  BMI: body mass index, DXA: 
dual-energy X-ray absorptiometry, FFM: fat-free mass, FFMI: fat-free mass index, FMI: fat-mass index  
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Table 3. A detailed description of athletes with one, two and ≥3 RED-S points 
Athlete Sport  Low RMR 




















1 RED-S points 
1  Wrestling YES (0.89) NO (+4.3) NO (21.0) NO (5.3) NO (479) NO (2.7) 8.1 
2  Kickboxing YES (0.68) NO (-0.4) NO (17.0) NO (5.2) NO (483) NO (2.6) 11.6 
3 Triathlon NO (1.06) YES (-1.2) NO (16.0) NO (6.3) NO (459) NO (2.6) 9.7 
4 Triathlon NO (1.06) YES (-1.1) NO (22.0) NO (6.7) NO (283) NO (2.7) 13.4 
5 Rowing NO (0.98) YES (-1.1) NO (30.0) NO (5.9) NO (390) NO (1.6) 17.9 
6 Rowing NO (1.08) YES (-1.9) NO (18.0) NO (6.0) NO (406) NO (2.2) 15.5 
2 RED-S points 
7  Kickboxing YES (0.77) NO (+3.2) YES (13.0) NO (4.8) NO (404) NO (2.0) 9.7 
8  Powerlift YES (0.89) NO (+0.3) YES (9.0) NO (6.5) NO (386) NO (2.6) 21.5 
9 Cycling NO (1.03) YES (-1.2) NO (20.0) NO (5.8) NO (478) YES (3.9) 13.3 
10 Cycling NO (1.06) YES (-1.8) NO (27.0) YES (3.6) NO (518) NO (1.9) 9.0 
11 Rowing NO (0.96) NO (+0.8) YES (13.0) NO (5.3) NO (451) YES (3.1) 8.1 
12 Nordic combined NO (0.92) NO (-0.8) NO (25.0) NO (5.1) YES (544) YES (3.1) 9.0 
13 Powerlift NO (1.04) NO (+1.5) YES (13.0) NO (5.4) NO (236) YES (4.9) 26.1 
≥3 RED-S points 
14 Cycling YES (0.77) NO (-0.1) YES (4.3) YES (3.9) YES (573) NO (2.8) 8.6 
15 Kickboxing YES (0.83) NO (+2.4) YES (13.0) NO (4.9) YES (711) NO (2.8) 14.1 
16 Powerlift YES (0.83) NO (+3.4) YES (13.0) NO (5.4) NO (222) YES (4.5) 26.1 
17 Powerlift NO (1.05) YES (-1.9) YES (12.0) NO (5.7) NO (417) YES (3.1) 35.4 
18 Rowing NO (1.08) NO (-0.5) YES (8.0) NO (5.4) YES (633) YES (3.1) 10.7 
Abbreviations: BMD: bone mineral density, RMR: resting metabolic rate, TES: total testosterone, fT3: free triiodothyronine, 
COR: cortisol, LDL: low-density lipoprotein, ( ) represent absolute values of measurements  




Table 4. Reproductive and metabolic hormones of athletes in total and categorized according to energetic status 
Measurement Total 
n = 44 
Low RMR 
n = 7 
Normal RMR 
n = 37 
P-value Effect size 
(95% CI) 
RMRratio 1.00 ± 0.13 0.81 ± 0.07 1.04 ± 0.09 <0.001 2.6 (1.6-3.6) 
Relative RMR (kcal·kgFFM-1·day-1) 29.4 ± 4.1 23.6 ± 1.8 30.4 ± 3.3 <0.001 2.2 (1.2-3.1) 
Total testosterone (nmol·l-1) 18.1 ± 5.9 12.9 ± 5.3 19.0 ± 5.3 0.020 1.2 (0.3-2.0) 
Free testosterone (nmol·l-1) 0.37 ± 0.11 0.28 ± 0.13 0.39 ± 0.10 0.061 1.1 (0.3-1.9) 
Free T3 (pmol·l-1) 5.6 ± 0.7 5.1 ± 0.8 5.7 ± 0.7 0.127 0.8 (0.0-1.6) 
Cortisol (nmol·l-1) 451 ± 115 465 ± 154 449 ± 106 0.789 0.2 (-1.0-0.7) 
TC (mmol·l-1) 4.7 ± 0.8 5.0 ± 0.8 4.6 ± 0.8 0.270 0.5 (-0.3-1.3) 
LDL (nmol·l-1) 2.7 ± 0.8 2.9 ± 0.8 2.6 ± 0.8 0.606 0.2 (-1.0-0.6) 
Data are presented as mean ± standard deviation. P-value and ES indicates difference between low and normal RMR 
group. Effect size expressed as Cohens D with 95% confidence interval (CI). Abbreviations: FFM: fat-free mass, T3: 
Triiodothyronine RMR: Resting metabolic rate, TC: total cholesterol, LDL: low-density lipoprotein. 
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Figure legends: 621 
Figure 1. Between-group and cumulative count (x-axis) of the numbers of RED-S criteria present among 622 
the athletes divided into leanness and non-leanness groups. Abbreviations: RED-S: relative energy 623 
deficiency in sport 624 
 625 
Figure 2. Individual RED-S criteria cumulative represented (x-axis) and numbers present within each 626 
athlete group (numbers displayed in each bar). Abbreviations: BMD: bone mineral density, COR: 627 
cortisol, fat%: fat percentage, LDL: low-density lipoprotein, RED-S: relative energy deficiency in 628 
sport, RMR: Resting metabolic rate, fT3: Free triiodothyronine, TES: testosterone.  629 
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